Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH
PolandAll drugs from this manufacturer
-
The medicine is used in the treatment of epilepsy to reduce the number of seizures. In adults with newly diagnosed epilepsy, it is used as monotherapy, whereas in adults, adolescents, and children over 6 years of age, it may be used as an adjunct to other anti-epileptic drugs.
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 200 mg ATC: N03AF04
-
The medicine is used to treat epilepsy to reduce the number of seizures. In adults, it may be used as monotherapy, whereas in adults, adolescents, and children over 6 years of age, it may be used as adjunctive therapy for partial seizures.
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 400 mg ATC: N03AF04
-
The medicine is used in the treatment of epilepsy in adults (as monotherapy) and in adults, adolescents, and children over 6 years of age (as adjunctive treatment for partial seizures). Its purpose is to reduce the number of epileptic seizures.
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 600 mg ATC: N03AF04
-
The medicinal product is used in the treatment of epilepsy in adults (as monotherapy) and in adults, adolescents, and children over 6 years of age (as adjunctive treatment for partial seizures). It is intended to reduce the number of seizures.
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 800 mg ATC: N03AF04
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It may be used alone or in combination with other anti-epileptic drugs.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 50 mg ATC: N03AX18
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It helps in the treatment of partial seizures and primarily generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 100 mg ATC: N03AX18
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and primarily in the treatment of initially generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 150 mg ATC: N03AX18
-
Trelema is used in the treatment of epilepsy to reduce the number of seizures. It may be used alone or in combination with other anti-epileptic drugs.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 200 mg ATC: N03AX18
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) in the case of epilepsy with partial seizures. It may also be used in combination with other medicines in children from 4 years of age for the treatment of primarily generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 50 mg or 100 mg or 150 mg or 200 mg ATC: N03AX18